Operations Excellence: BioPharma Operations Excellence - Survey indicates that biopharma is fully engaged in operations excellence, with an expanding role for suppliers. - BioPharm International

ADVERTISEMENT

Operations Excellence: BioPharma Operations Excellence
Survey indicates that biopharma is fully engaged in operations excellence, with an expanding role for suppliers.


BioPharm International


Survey participants were also asked about which cost elements are taken into consideration when calculating their overall equipment cost of ownership. Responses revealed that many significant cost components such as spare parts, consumables, and cost of failures, are not included by most companies in their overall cost evaluation and comparison.

Industry managers commented during panel discussions that there appears to be a growing acceptance of the valuable role a supplier can play in developing optimized product and service solutions. By following examples in other advanced industries such as the semiconductor industry, suppliers could become essential partners in developing biopharma processes and operational excellence. Wise partnership models would allow manufacturing companies to rely on the expertise suppliers have gained from working with various manufacturing companies and on their vast understanding of regulatory requirements.

For more information related to consortium activity or the biopharma survey, please visit Tefen's website http://www.tefen.com/ or e-mail

Amir London is a partner at Tefen Ltd, 1065 East Hillsdale Blvd, #421, Foster City, CA, 650.357.1120, ext. 115, fax: 650.372.1350,


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Panel Unanimously Backs Secukinumab for the Treatment of Psoriasis
October 22, 2014
Roche to Expand and Improve its Basel Site
October 22, 2014
Pall ForteBio Releases Bioprocessing Contamination Detection Kit
October 22, 2014
EMA Works to Speed Up Ebola Treatment
October 20, 2014
Amgen Sues Sanofi and Regeneron over Patent for mAb Targeting PCSK9
October 20, 2014
Author Guidelines
Source: BioPharm International,
Click here